• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Comput Methods Programs Biomed . Prediction of death status on the course of treatment in SARS-COV-2 patients with deep learning and machine learnin

tetano

Editor, Senior Moderator
Comput Methods Programs Biomed


. 2021 Jan 22;201:105951.
doi: 10.1016/j.cmpb.2021.105951. Online ahead of print.
Prediction of death status on the course of treatment in SARS-COV-2 patients with deep learning and machine learning methods


Mehmet Kivrak[SUP] 1 [/SUP], Emek Guldogan[SUP] 1 [/SUP], Cemil Colak[SUP] 2 [/SUP]



Affiliations
Free PMC article

Abstract

Background and objective: The new type of Coronavirus (2019-nCov) epidemic spread rapidly, causing more than 250 thousand deaths worldwide. The virus, which first appeared as a sign of pneumonia, was later called the SARS-COV-2 with Severe Acute Respiratory Syndrome by the World Health Organization. The SARS-COV-2 virus is triggered by binding to the Angiotensin-Converting Enzyme 2 (ACE 2) inhibitor, which is vital in cardiovascular diseases and the immune system, especially in conditions such as cerebrovascular, hypertension, and diabetes. This study aims to evaluate the prediction performance of death status based on the demographic/clinical factors (including COVID-19 severity) by data mining methods.
Methods: The dataset consists of 1603 SARS-COV-2 patients and 13 variables obtained from an open-source web address. The current dataset contains age, gender, chronic disease (hypertension, diabetes, renal, cardiovascular, etc.), some enzymes (ACE, angiotensin II receptor blockers), and COVID-19 severity, which are used to predict death status using deep learning and machine learning approaches (random forest, k-nearest neighbor, extreme gradient boosting [XGBoost]). A grid search algorithm tunes hyperparameters of the models, and predictions are assessed through performance metrics. Steps of knowledge discovery in databases are applied to obtain the relevant information.
Results: The accuracy rate of deep learning (97.15%) was more successful than the accuracy rate based on classical machine learning (92.15% for RF and 93.4% for k-NN), but the ensemble classifier XGBoost method gave the highest accuracy (99.7%). While COVID-19 severity and age calculated from XGBoost were the two most important factors associated with death status, the most determining variables for death status estimated from deep learning were COVID-19 severity and hypertension.
Conclusions: The proposed model (XGBoost) achieved the best prediction of death status based on the factors as compared to the other algorithms. The results of this study can guide patients with certain variables to take early measures and access preventive health care services before they become infected with the virus.

Keywords: Data Mining; Deep Learning; Extreme Gradient Boosting; Machine Learning; SARS-COV-2.
 
Back
Top Bottom